Ris-Rez: Clinical Trials

2 trials of Ris-Rez, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2
Phase 11Recruiting 1

Follow Ris-Rez: new trials by email Literature Review of Ris-Rez trials Research Report on Ris-Rez

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations
HS-20093 for Injection, Adebrelimab Injection - Non-Small Cell Lung Cancer
Phase 2RecruitingHansoh BioMedical R&D Company762026-10-082026-10-23
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Ris-Rez, G-CSF - Sarcoma
Phase 1 / Phase 2RecruitingGlaxoSmithKline642026-06-222026-10-01

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Sarcoma (1)

Sponsors

GlaxoSmithKline (1)  ·  Hansoh BioMedical R&D Company (1)

Countries

Canada (1)  ·  China (1)  ·  France (1)  ·  Israel (1)  ·  Japan (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2025 (1)